Catalyst
Slingshot members are tracking this event:
Tesaro (TSRO) Expects Launch of VARUBI IV in U.S in Mid-2017 for Chemotherapy-Induced Nausea and Vomiting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TSRO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 08, 2017
Occurred Source:
http://ir.tesarobio.com/releasedetail.cfm?ReleaseID=1036568
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Varubi Iv, Chemotherapy-induced Nausea And Vomiting
